Sickle Cell Disease Patient Recruitment in New York

TheraNovex connects clinical trial sponsors with pre-screened, eligible Sickle Cell Disease patients across New York, including New York City, Buffalo, Rochester, and beyond.

Sickle cell disease patient recruitment for HbSS, HbSC, and gene therapy clinical trials.

Who qualifies: Patients with SCD (HbSS, HbSC, HbSβ⁰-thalassemia) aged 12+ with history of vaso-occlusive crises.

Recruitment challenges: Hemoglobin genotype confirmation and prior hydroxyurea treatment eligibility.

Our approach: Sickle cell disease center networks, patient advocacy partnerships, and genotype pre-screening.

Our recruitment network spans all major metropolitan areas in New York, ensuring broad geographic coverage for your Sickle Cell Disease trial.